Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia

European Journal of Clinical Microbiology & Infectious Diseases

Volumn 10, Issue 10, 1991, Pages 872-877

  Kinasewitz, G ^a   Wood, R G ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFACLOR;

ARTICLE; BACTERIAL PNEUMONIA; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; VOMITING;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AZITHROMYCIN; BACTERIAL INFECTIONS; CEFACLOR; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ERYTHROMYCIN; FEMALE; HUMAN; MALE; MIDDLE AGE; PNEUMONIA;

EID: 0025999735     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/BF01975846     Document Type: Article

References (12)

1. Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a homoerythromycin A derivatives: a new class of macrolides, the azalides
2. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with extended half life and excellent tissue distribution
3. The pharmacokinetics of azithromycin in human serum and tissues
4. Azithromycin concentrations at the site of pulmonary infection
5. Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol
6. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms
7. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides
8. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution
9. Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo
10. A comparative study of azithromycin and amoxicillin in the treatment of lower respiratory tract infections
11. A multicentre trial comparing the efficacy and safety of cefuroxime axetil and cefaclor in pneumonia of adults
12. Clinical evaluation of BMY-28100 for bacterial pneumonia in comparison with cefaclor in a double-blind study